Form 4: Therapeutic Solutions International CEO Acquires Shares at Discounted Price
SEC Form 4 Filing
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, Inc., reports acquiring 42,857,142 shares of common stock at $0.0007 per share on April 18, 2024.
Summary
- On April 18, 2024, Timothy G. Dixon, the President & CEO, Director, and a 10% Owner of Therapeutic Solutions International, Inc. (TSOI), acquired 42,857,142 shares of common stock.
- The acquisition price was $0.0007 per share.
- Following the transaction, Dixon's total beneficial ownership in TSOI is 411,850,245 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While insider buying can be positive, the very low price per share raises concerns.
Positives
- The CEO's purchase of a significant number of shares could be interpreted as a sign of confidence in the company's future prospects.
Risks
- The acquisition price of $0.0007 per share is very low, which could raise questions about the company's valuation and financial health.
Industry Context
This type of SEC filing is standard for corporate insiders who trade in their company's stock. It provides transparency to the market about insider activity.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the stock transaction. |
| 04/19/2024 | Date of signature on the Form 4 filing. |
Keywords
Therapeutic Solutions International, TSOI, Timothy G. Dixon, stock acquisition, beneficial ownership, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.